Ignite Creation Date:
2024-05-05 @ 5:20 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00432523
Status:
COMPLETED
Last Update Posted:
2021-10-18
First Post:
2007-02-07
Brief Title:
Immunogenicity and Safety of Concomitant Administration of MMR rHA and VARIVAX by Intramuscular Versus Subcutaneous Route V205C-011
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-01-20
Start Date Type:
ACTUAL
Primary Completion Date:
2005-09-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2005-09-05
Completion Date Type:
ACTUAL
First Submit Date:
2007-02-07
First Submit QC Date:
February 7 2007
Study First Post Date:
2007-02-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-10-11
Last Update Post Date:
2021-10-18
Last Update Post Date Type:
ACTUAL